Ankara Bilkent Şehir Hastanesi
Ankara, 06800, Turkey (Türkiye)
NCT Number: NCT06165848
Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Observational
Ankara, 06800, Turkey (Türkiye)
Aim: Adequate and effective pain management and prevention of depression are essential in burn patients. This study aims to investigate the effects of ketamine sedation in burn patients in terms of mood disorders, depression, anxiety, and suicidal tendency during intensive care follow-up in the postoperative period.
Methods: The study was conducted with 67 patients between 18 and 65 years of age, who were ASA I-II class, had basic communication skills, no previous diagnosis of psychiatric illness, and no history of neuropsychiatric or cognitive disease or related treatment. After preoxygenation, anesthesia induction was performed with 2 mg/kg IV propofol and 1 mcg/kg IV fentanyl in the general anesthesia group. Anesthesia was continued with a mixture of 0.3-0.5 mcg/kg/min remifentanil, 2% sevoflurane, 50% air, 50% oxygen. In the sedation group, 1 mcg/kg IV fentanyl and 1 mg/kg IV ketamine were administered at induction; anesthesia was maintained by adding 30-50 mg IV propofol if necessary. The Montgomery-Asberg Depression Rating Scale (MADRS), the Hamilton Anxiety Rating Scale (HAM-A), and the Beck Scale for Suicide Ideation (BSSI) were administered preoperatively and on postoperative day one by the psychiatrist.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 72 hours
In order to determine whether there is negative mood and depression; Montgomery-Asberg Depression Rating Scale (MADRS) was administered by the psychiatrist .
Time frame: 72 hours
For anxiety; Hamilton Anxiety Rating Scale (HAM-A) was administered by the psychiatrist .
Time frame: 72 hours
To determine whether there is suicidal ideation; Beck Suicidal Ideation Scale (BSSI) was administered by the psychiatrist .
Looking for future studies?
Notify MeT.C. Sağlık Bakanlığı Ankara Bilkent Şehir Hastanesi
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06934135
Behavior, Behavioral Symptoms
Lima, Lima Province, Peru
View Trial DetailsNCT00044174
Behavior, Behavioral Symptoms
Bethesda, Maryland, United States
View Trial DetailsNCT04021329
Anxiety Disorders, Anxiety Symptoms
Peshawar, KPK, Pakistan
View Trial DetailsNCT05349877
Anxiety, Anxiety Disorders
Porto Alegre, Rio Grande do Sul, Brazil
View Trial Details